Correlation Between X4 Pharmaceuticals and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Kymera Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Kymera Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Kymera Therapeutics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between XFOR and Kymera is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Kymera Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 2.4 times more return on investment than Kymera Therapeutics. However, X4 Pharmaceuticals is 2.4 times more volatile than Kymera Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 79.00 in X4 Pharmaceuticals on November 9, 2024 and sell it today you would lose (24.00) from holding X4 Pharmaceuticals or give up 30.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Kymera Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Kymera Therapeutics |
X4 Pharmaceuticals and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Kymera Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |